Shoshanna Fischhoff

Care.com interviewed Eva Feldman, M.D., Ph.D., for an article about dealing with loved ones who have dementia and anosognosia.

Researchers investigated whether obesity measurements might provide an early warning for diabetic peripheral neuropathy

Tofacitinib, an FDA-approved drug, was tested on an ALS mouse model.

Radio Health Journal interviewed Dr. Eva Feldman about neuropathy, from what it is and its causes to treatment and prevention.

We look back at an incredible year by the numbers and a timeline of key moments.

Researchers study air pollution as a modifiable risk factor for deadly neurological disease.

A research team reviewed the latest discoveries related to genome-wide association studies and dementia.

The magazine that has served the welding community for over 20 years talks about our research into environmental exposures and the innovative Michigan Brain, Health & Environment Study.

Dr. Feldman receives significant new funding to advance the ability to predict and ultimately prevent ALS.

Researchers identified distinct gene expression patterns that distinguish ALS patients.

The NeuroNetwork for Emerging Therapies was part of The Neighborhoods Study, a nationwide effort to examine how where people live affects Alzheimer’s disease and related dementias.

The official source of the American Academy of Neurology intereviewed her for an article titled "How Brooke Eby is Using Humor and Honesty to Redefine Life with ALS."

A monthly photo hot off the presses from our research showing how beautiful science can be.

We sat down with the Robert A. Epstein and Joan M. Chernoff-Epstein Emerging Scholar to hear about his work at the intersection of immunology and ALS.

The grant funds the use of a new tool to aid in better understanding the immune system’s role in the disease.